BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 17848376)

  • 21. Efficacy of β-Lactam/β-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in Hematological Patients with Neutropenia.
    Gudiol C; Royo-Cebrecos C; Abdala E; Akova M; Álvarez R; Maestro-de la Calle G; Cano A; Cervera C; Clemente WT; Martín-Dávila P; Freifeld A; Gómez L; Gottlieb T; Gurguí M; Herrera F; Manzur A; Maschmeyer G; Meije Y; Montejo M; Peghin M; Rodríguez-Baño J; Ruiz-Camps I; Sukiennik TC; Tebe C; Carratalà J;
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detecting risk and predicting patient mortality in patients with extended-spectrum β-lactamase-producing Enterobacteriaceae bloodstream infections.
    Trecarichi EM; Cauda R; Tumbarello M
    Future Microbiol; 2012 Oct; 7(10):1173-89. PubMed ID: 23030423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Multinational, Preregistered Cohort Study of β-Lactam/β-Lactamase Inhibitor Combinations for Treatment of Bloodstream Infections Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae.
    Gutiérrez-Gutiérrez B; Pérez-Galera S; Salamanca E; de Cueto M; Calbo E; Almirante B; Viale P; Oliver A; Pintado V; Gasch O; Martínez-Martínez L; Pitout J; Akova M; Peña C; Molina J; Hernández A; Venditti M; Prim N; Origüen J; Bou G; Tacconelli E; Tumbarello M; Hamprecht A; Giamarellou H; Almela M; Pérez F; Schwaber MJ; Bermejo J; Lowman W; Hsueh PR; Mora-Rillo M; Natera C; Souli M; Bonomo RA; Carmeli Y; Paterson DL; Pascual A; Rodríguez-Baño J
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4159-69. PubMed ID: 27139473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of the clinical significance of production of extended-spectrum beta-lactamases (ESBL) by Enterobacteriaceae.
    Henshke-Bar-Meir R; Yinnon AM; Rudensky B; Attias D; Schlesinger Y; Raveh D
    Infection; 2006 Apr; 34(2):66-74. PubMed ID: 16703295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of place of acquisition and inappropriate empirical antibiotic therapy on the outcome of extended-spectrum β-lactamase-producing Enterobacteriaceae infections.
    Tacconelli E; Cataldo MA; Mutters NT; Carrara E; Bartoloni A; Raglio A; Cauda R; Mantengoli E; Luzzaro F; Pan A; Beccara LA; Pecile P; Tinelli M; Rossolini GM
    Int J Antimicrob Agents; 2019 Jul; 54(1):49-54. PubMed ID: 30986523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extended-spectrum-β-lactamase-producing Enterobacteriaceae.
    Palacios-Baena ZR; Gutiérrez-Gutiérrez B; De Cueto M; Viale P; Venditti M; Hernández-Torres A; Oliver A; Martínez-Martínez L; Calbo E; Pintado V; Gasch O; Almirante B; Antonio Lepe J; Pitout J; Akova M; Peña-Miralles C; Schwaber MJ; Tumbarello M; Tacconelli E; Origüen J; Prim N; Bou G; Giamarellou H; Bermejo J; Hamprecht A; Pérez F; Almela M; Lowman W; Hsueh PR; Navarro-San Francisco C; Torre-Cisneros J; Carmeli Y; Bonomo RA; Paterson DL; Pascual Á; Rodríguez-Baño J;
    J Antimicrob Chemother; 2017 Mar; 72(3):906-913. PubMed ID: 28062685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of mortality from extended-spectrum beta-lactamase-producing Enterobacteriaceae bacteremia.
    Namikawa H; Imoto W; Yamada K; Tochino Y; Kaneko Y; Kakeya H; Shuto T
    Emerg Microbes Infect; 2023 Dec; 12(1):2217951. PubMed ID: 37219067
    [No Abstract]   [Full Text] [Related]  

  • 28. Carbapenems Versus Piperacillin-Tazobactam for Bloodstream Infections of Nonurinary Source Caused by Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae.
    Ofer-Friedman H; Shefler C; Sharma S; Tirosh A; Tal-Jasper R; Kandipalli D; Sharma S; Bathina P; Kaplansky T; Maskit M; Azouri T; Lazarovitch T; Zaidenstein R; Kaye KS; Marchaim D
    Infect Control Hosp Epidemiol; 2015 Aug; 36(8):981-5. PubMed ID: 25990361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is It Time to Rethink the Notion of Carbapenem-Sparing Therapy Against Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Bloodstream Infections? A Critical Review.
    Chastain DB; White BP; Cretella DA; Bland CM
    Ann Pharmacother; 2018 May; 52(5):484-492. PubMed ID: 29239220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mortality impact of empirical antimicrobial therapy in ESBL- and AmpC-producing Enterobacteriaceae bacteremia in an Australian tertiary hospital.
    Lim CL; Spelman D
    Infect Dis Health; 2019 Aug; 24(3):124-133. PubMed ID: 30928569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Risk Score for Prediction of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Bloodstream Isolates.
    Augustine MR; Testerman TL; Justo JA; Bookstaver PB; Kohn J; Albrecht H; Al-Hasan MN
    Infect Control Hosp Epidemiol; 2017 Mar; 38(3):266-272. PubMed ID: 27989244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colonisation with extended-spectrum β-lactamase-producing Enterobacteriaceae and risk for infection among patients with solid or haematological malignancy: a systematic review and meta-analysis.
    Alevizakos M; Karanika S; Detsis M; Mylonakis E
    Int J Antimicrob Agents; 2016 Dec; 48(6):647-654. PubMed ID: 27746102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A simple scoring algorithm predicting extended-spectrum β-lactamase producers in adults with community-onset monomicrobial Enterobacteriaceae bacteremia: Matters of frequent emergency department users.
    Lee CH; Chu FY; Hsieh CC; Hong MY; Chi CH; Ko WC; Lee CC
    Medicine (Baltimore); 2017 Apr; 96(16):e6648. PubMed ID: 28422867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical epidemiology, risk factors and treatment outcomes of extended-spectrum beta-lactamase producing Enterobacteriaceae bacteremia among children in a Tertiary Care Hospital, Bangkok, Thailand.
    Nivesvivat T; Piyaraj P; Thunyaharn S; Watanaveeradej V; Suwanpakdee D
    BMC Res Notes; 2018 Aug; 11(1):624. PubMed ID: 30157960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors for onset of extended-spectrum beta-lactamase-producing Escherichia coli-induced bacteraemia: a systematic review and meta-analysis.
    Namikawa H; Imoto W; Yamada K; Tochino Y; Kaneko Y; Kakeya H; Shuto T
    J Hosp Infect; 2023 Dec; 142():88-95. PubMed ID: 37802238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bacteremia due to extended-spectrum beta-lactamase-producing Enterobacteriaceae other than Escherichia coli and Klebsiella.
    Huang SS; Lee MH; Leu HS
    J Microbiol Immunol Infect; 2006 Dec; 39(6):496-502. PubMed ID: 17164953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbapenem-sparing beta-lactam/beta-lactamase inhibitors versus carbapenems for bloodstream infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae: a systematic review and meta-analysis.
    Zhang H; Xu J; Xiao Q; Wang Y; Wang J; Zhu M; Cai Y
    Int J Infect Dis; 2023 Mar; 128():194-204. PubMed ID: 36621752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bloodstream infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae among patients with malignancy: a systematic review and meta-analysis.
    Alevizakos M; Gaitanidis A; Andreatos N; Arunachalam K; Flokas ME; Mylonakis E
    Int J Antimicrob Agents; 2017 Nov; 50(5):657-663. PubMed ID: 28705665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical significance of extended-spectrum beta-lactamases.
    Rodríguez-Baño J; Pascual A
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):671-83. PubMed ID: 18847405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology and clinical outcomes of bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli in patients with cancer.
    Ha YE; Kang CI; Cha MK; Park SY; Wi YM; Chung DR; Peck KR; Lee NY; Song JH
    Int J Antimicrob Agents; 2013 Nov; 42(5):403-9. PubMed ID: 24071027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.